Aeglea Biotherapeutics - Investors - Investors

Investor info Aeglea BioTherapeutics researching enzyme treatment and therapeutic human engineered enzymes to help treat cancer and rare genetic disease.

OVERVIEW

The domain ir.aegleabio.com currently has a traffic classification of zero (the lower the more users). We have traversed zero pages within the domain ir.aegleabio.com and found eighteen websites referencing ir.aegleabio.com. We have discovered one mass web sites possessed by ir.aegleabio.com.
Links to this site
18
Social Links
1

IR.AEGLEABIO.COM TRAFFIC

The domain ir.aegleabio.com has seen fluctuating levels of traffic through the year.
Traffic for ir.aegleabio.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.aegleabio.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.aegleabio.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEBSITE

Home Page Aeglea Biotherapeutics

Exploiting Errors in Metabolism to Advance Treatment of Human Disease. Developing variants on human enzymes to deplete key amino acids driving human disease.

WHAT DOES IR.AEGLEABIO.COM LOOK LIKE?

Desktop Screenshot of ir.aegleabio.com Mobile Screenshot of ir.aegleabio.com Tablet Screenshot of ir.aegleabio.com

IR.AEGLEABIO.COM SERVER

We observed that the main root page on ir.aegleabio.com took one thousand one hundred and twenty-five milliseconds to come up. I could not observe a SSL certificate, so in conclusion our web crawlers consider this site not secure.
Load time
1.125 sec
SSL
NOT SECURE
IP
184.25.56.203

SITE TITLE

Aeglea Biotherapeutics - Investors - Investors

DESCRIPTION

Investor info Aeglea BioTherapeutics researching enzyme treatment and therapeutic human engineered enzymes to help treat cancer and rare genetic disease.

PARSED CONTENT

The domain ir.aegleabio.com had the following in the web page, "As of 011117 400 pm ET." I observed that the webpage stated " Aeglea BioTherapeutics to Present at BMO Capital Markets Prescription for Success Healthcare Conference." They also stated " AUSTIN, Texas, Dec. 07, 2016 GLOBE NEWSWIRE - Aeglea BioTherapeutics, Inc. NASDAQAGLE, a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat genetic rare diseases and cancer,. There are currently no events scheduled."

ANALYZE OTHER DOMAINS

ООО Газпром газораспределение Волгоград Главная страница

Интерактивная карта зон обслуживания Волгоградской области. Волгоградские газовики совместно с МЧС и Жилинспекцией выявили более 130 нарушений правил использования газа в быту. Компания Газпром газораспределение Волгоград проводит рейды совместно с МЧС и Жилинспекцией.

АО Газпром бытовые системы - производитель газовых, электрических, комбинированных, настольных кухонных плит, встраиваемой техники

В состав холдинга АО Газпром бытовые системы входят три филиала и два дочерних общества. АО Газпром бытовые системы является дочерним обществом ПАО Газпром. По объемам производства бытовых газовых плит и комплектующих изделий для газовой аппаратуры АО Газпром бытовые системы многие десятилетия является лидером в Российской Федерации. С Новым годом и Рождеством! Новые модели встраиваемой техники. 2017 АО Газпром бытовые системы.

Sobre o Programa

Documento Base do Programa Microgravidade.

Startseite - TH Köln

Human Resources Strategy for Researchers. Kunst, Kultur und Bau. Technik, Umwelt und Natur. Anlagen, Energie- und Maschinensysteme. Informations-, Medien- und Elektrotechnik. Institut für Technologie und Ressourcenmanagement in den Tropen und Subtropen.

Sobre o programa

Criado pela Agência Espacial Brasileira. Seu principal objetivo é formar uma base sólida de pesquisa e desenvolvimento composta por núcleos especializados capazes de executar projetos na área espacial.